Indeed, a study suggested that assessment of cytoplasmic cadherin-1 staining can predict time to BCa recurrence [21] while Mahnken et al. found a correlation between abnormal cadherin-1 immunostaining and early tumor recurrence, identifying this parameter as an independent predictor of recurrence-free survival [22]. The gene discussed is CDH1; the disease is neoplasm.